T2 Biosystems (NASDAQ:TTOO) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a report released on Wednesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Down 1.5 %

NASDAQ TTOO opened at $0.12 on Wednesday. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80. The firm’s fifty day moving average price is $0.17 and its two-hundred day moving average price is $0.72.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.